The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2− Breast Cancer

E2F transcription factors play critical roles in the cell cycle. Therefore, their activity is expected to reflect tumor aggressiveness and responsiveness to therapy. We scored 3905 tumors of nine breast cancer cohorts for this activity based on their gene expression for the Hallmark E2F targets gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshi, Masanori, Takahashi, Hideo, Tokumaru, Yoshihisa, Yan, Li, Rashid, Omar M., Nagahashi, Masayuki, Matsuyama, Ryusei, Endo, Itaru, Takabe, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407968/
https://www.ncbi.nlm.nih.gov/pubmed/32650578
http://dx.doi.org/10.3390/cells9071643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407968/
https://www.ncbi.nlm.nih.gov/pubmed/32650578
http://dx.doi.org/10.3390/cells9071643

Ejemplares similares